Total Payments
$8,759
2024 Payments
$1,575
Companies
41
Transactions
281
Medicare Patients
14,782
Medicare Billing
$4.0M
Payment Breakdown by Category
Food & Beverage$8,714 (99.5%)
Gifts$45.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,714 | 280 | 99.5% |
| Gift | $45.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $1,489 | 28 | $0 (2024) |
| Alcon Vision LLC | $949.10 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $486.27 | 17 | $0 (2024) |
| Shire North American Group Inc | $462.46 | 28 | $0 (2019) |
| Alcon Laboratories Inc | $423.85 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $375.05 | 7 | $0 (2024) |
| RxSight Inc | $374.23 | 8 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $358.37 | 14 | $0 (2021) |
| Allergan, Inc. | $356.98 | 14 | $0 (2021) |
| Genentech USA, Inc. | $354.63 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,575 | 55 | Astellas Pharma US Inc ($193.67) |
| 2023 | $1,413 | 45 | Alcon Vision LLC ($260.84) |
| 2022 | $1,431 | 43 | GLAUKOS CORPORATION ($344.03) |
| 2021 | $950.82 | 26 | Glaukos Corporation ($421.86) |
| 2020 | $523.61 | 21 | Glaukos Corporation ($165.98) |
| 2019 | $644.30 | 23 | Novartis Pharmaceuticals Corporation ($160.97) |
| 2018 | $958.04 | 36 | Alcon Laboratories Inc ($277.40) |
| 2017 | $1,263 | 32 | Valeant Pharmaceuticals North America LLC ($280.75) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Dry eyes | ||||||
| 11/13/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | ANI Pharmaceuticals, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $110.21 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $120.87 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $37.33 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Ophthalmology | ||||||
| 10/16/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Dry eyes | ||||||
| 08/28/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: OPTOMETRY | ||||||
| 08/20/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/19/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| 07/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/29/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $22.63 | General |
| 07/24/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Dry eyes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,259 | 152,434 | $3.2M | $999,526 |
| 2022 | 24 | 3,674 | 8,716 | $2.9M | $912,967 |
| 2021 | 24 | 3,997 | 7,191 | $3.2M | $1.1M |
| 2020 | 22 | 3,852 | 6,791 | $2.9M | $995,767 |
Total Patients
14,782
Total Services
175,132
Medicare Billing
$4.0M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 64 | 12,780 | $689,400 | $366,183 | 53.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 60 | 955 | $411,930 | $172,363 | 41.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 170 | 299 | $598,000 | $110,306 | 18.4% |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 2023 | 87 | 134,400 | $198,000 | $68,596 | 34.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 15 | 82 | $123,000 | $56,747 | 46.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 482 | 483 | $72,450 | $39,147 | 54.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 132 | 411 | $360,360 | $36,566 | 10.1% |
| 92134 | Imaging of retina | Office | 2023 | 711 | 1,030 | $144,200 | $28,502 | 19.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 82 | 120 | $114,950 | $28,416 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 321 | 448 | $44,800 | $26,467 | 59.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 200 | 200 | $36,000 | $19,228 | 53.4% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 21 | 21 | $63,000 | $10,623 | 16.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 235 | 335 | $49,875 | $9,524 | 19.1% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 15 | 15 | $42,000 | $8,337 | 19.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 136 | 140 | $17,500 | $5,994 | 34.3% |
| 68841 | Insertion of drug delivery implant into tear duct of eye | Facility | 2023 | 169 | 295 | $236,000 | $3,721 | 1.6% |
| 92250 | Photography of the retina | Office | 2023 | 104 | 105 | $10,290 | $2,525 | 24.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 98 | 103 | $14,420 | $2,302 | 16.0% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 38 | 84 | $3,360 | $1,851 | 55.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 16 | 16 | $1,920 | $802.68 | 41.8% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 19 | 19 | $1,900 | $584.53 | 30.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 65 | 74 | $2,960 | $517.54 | 17.5% |
| 92285 | Photography of content of eyes | Office | 2023 | 19 | 19 | $1,691 | $223.24 | 13.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 65 | 1,321 | $558,783 | $293,947 | 52.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 35 | 233 | $349,500 | $167,600 | 48.0% |
About Dr. Scott Mcknight, MD
Dr. Scott Mcknight, MD is a Ophthalmology healthcare provider based in Liberty, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164458998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Mcknight, MD has received a total of $8,759 in payments from pharmaceutical and medical device companies, with $1,575 received in 2024. These payments were reported across 281 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,714).
As a Medicare-enrolled provider, Mcknight has provided services to 14,782 Medicare beneficiaries, totaling 175,132 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Liberty, MO
- Active Since 06/23/2006
- Last Updated 03/11/2009
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1164458998
Products in Payments
- XIIDRA (Drug) $670.43
- ORA (Device) $436.99
- ACTHAR (Biological) $359.34
- CRYSTALENS (Device) $288.67
- IACCESS (Device) $264.45
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $248.30
- KXL System (Device) $212.31
- Clareon (Device) $199.76
- Cequa (Drug) $198.96
- Izervay (Drug) $193.67
- Cimerli (Biological) $193.60
- TYRVAYA (Drug) $190.62
- VYZULTA (Drug) $169.59
- Bromsite (Drug) $160.56
- Symfony (Medical Supply) $159.35
- OXERVATE (Drug) $157.21
- iStent inject W (Device) $155.88
- HYDRUS Microstent (Device) $153.17
- DURYSTA (Drug) $148.63
- iStent Trabecular Micro-Bypass Stent System (Device) $142.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Liberty
Brett Mcknight, M.d, M.D
Ophthalmology — Payments: $13,143
Ophthalmology $13,143
Dustin Mcknight, Md, MD
Ophthalmology — Payments: $8,300
Ophthalmology $8,300
Dr. Susan Carney, Md, MD
Ophthalmology — Payments: $2,104
Ophthalmology $2,104
Theodore Isseks, Md, MD
Ophthalmology — Payments: $790.41
Ophthalmology $790.41
Taylor Lind
Ophthalmology — Payments: $62.67
Ophthalmology $62.67